Louis P. Kassa III, MPA, chief executive officer of the Hepatitis B Foundation, Baruch S. Blumberg Institute and Pennsylvania Biotechnology Center (PABC), was awarded an honorary Doctor of Humane Letters at Holy Family University’s recent 2025 Graduate Commencement

In today’s economic environment, even the most innovative life science companies are forced to make hard decisions, such as downsizing teams, consolidating operations or pausing ambitious growth plans. While these transitions are challenging, they also open the

For the third straight year, Louis P. Kassa III, MPA, chief executive officer of the Hepatitis B Foundation, Baruch S. Blumberg Institute and Pennsylvania Biotechnology Center (PABC), has been chosen by the Philadelphia Business Journal for its 2025 Power

Lifesaving research by scientists, doctors and others around our country is being threatened by what’s happening currently in Washington, D.C., say officials of the Hepatitis B Foundation, Baruch S. Blumberg Institute and Pennsylvania Biotechnology Center (PABC).  “Medical

BUCKS COUNTY – November 1, 2024 – State Senator Steve Santarsiero (D-10) announced today $7,449,800 million in state funds from the Redevelopment Assistance Capital Program (RACP) for eight projects across the 10th Senate District.The awards are as follows:$500,000 to Bristol

The Hepatitis B Foundation, Baruch S. Blumberg Institute and Pennsylvania Biotechnology Center (PABC) announced today (Nov. 1) that Allen B. Reitz, PhD, Chief Executive Officer of Fox Chase Therapeutics Discovery Inc., has been chosen for the second annual

New York State officials today announced the team that has been selected to build and launch BioGenesis, a cell and gene therapy center on Long Island, which will include a biotech incubator to be managed by the

This year’s Regional Biotechnology Conference at the PABC also will feature a panel discussion with top life sciences CEOs in the region. Rick Siger, Pennsylvania Secretary of Community and Economic Development, and Jennifer Griffin, PhD, partner with

Dr. Timothy Block will share his thoughts about launching the Foundation, Blumberg Institute and Pennsylvania Biotechnology Center (PABC). When Timothy M. Block, PhD, an award-winning virologist and accomplished inventor, launched the Pennsylvania Biotechnology Center (PABC) in 2006,

Biotech entrepreneur and Blumberg Institute professor Kunwar Shailubhai, PhD, the pioneer of therapeutic applications of guanylate cyclase-C (GC-C) signaling and an inventor of the widely prescribed medicine Trulance(R), has been awarded a Phase 1 SBIR grant from